Clariant (India) Ltd.

YEAR                       EVENTS
 1947 - The company was Incorporated at Mumbai.  In January, a
 trading
        company was registered in India under the name of Sandoz
 Products
        Ltd., for the sale and distribution of products manufactured
 by
        Sandoz, Ltd., Switzerland.  The Company manufactures and deals
 in
        Pharmaceuticals, textile chemicals, dyestuffs, agrochemicals
 and
        chemical preparations of all kinds.
 
 1956 - The Sandoz Products, Ltd., obtained permission to establish a
 new
        industrial undertaking to manufacture calcium salts,
        pharmaceutical specialities and Leucophor.
 
 1958 - The Company entered into a 10 year collaboration agreement
 with
        Sandoz, Ltd. Switzerland, for manufacture of pharmaceuticals
 and
        textile chemicals.  The Company was permitted to use a number
 of
        trade marks of Sandoz, Ltd., Switzerland.
 
 1959 - With a paid-up capital of Rs 10 lakhs.  The capital was raised
 to
        Rs 50 lakhs in 1954 and to Rs 75 lakhs in 1958.
 
 1961 - At the time of incorporation, the name of the Company was
 Sandoz
        Products, Ltd.  The name was changed to Sandoz (India Ltd.)
 in
        June.  The name was again changed to Clariant (India) Ltd.
 with
        effect from 1st April, 1995.
 
 1964 - The Company entered into another 10 year agreement with
 Sandoz,
        Ltd., Switzerland, for the manufacture of dyestuffs against
        reimbursement of actual expenses incurred and payment of a
 sum
        not exceeding the net annual ex-factory sales (exclusive of
        freight of the dyestuffs manufactured or Rs 2 lakhs,
 whichever
        is less).
 
      - The Company also entered into another agreement with Sandoz.,
        Ltd. Switzerland, for obtaining the know how for the
 manufacture
        of products under the Phytochemicals Scheme for a
 consideration
        of Rs 4 lakhs to be paid to the collaborators in the form of
        Equity shares.
 
      - The Company further agreed to reimburse Sandoz, Ltd. Basle,
        Switzerland, the actual expenses not exceeding Rs 2 lakhs per
        annum that might be incurred by them from 1st January, for a 
        period of 5 years for rendering technical assistance to the
        company for the manufacture of Podophyllum extract.
 
      - Shares subdivided in November.  7,50,000 shares then issued by
 a
        Prospectus.  Out of the issue: (i) 2,36,000 shares allotted
 to
        Sandoz, Ltd., Switzerland, out of which 1,36,000 shares were
        allowed for cash.  (ii) 75,000 shares allotted for cash Shaw
        Wallace & Co., Ltd., (iii) 1,39,000 shares reserved allotment
 to
        existing shareholders, Directors, their friends and
 associates;
        and (iv) 3,00,000 shares offered for public subscription in
        December.
 
 1967 - 275 No. of equity shares forfeited for non-payment of calls.
 
 1968 - 275 No. of equity shares reissued during the year.
 
 1969 - The Company acquired 22,500 equity shares of Rs 10 each of
        Wander, Ltd., a company formed by combining the interest of
        Sandoz and Wander and in which Dr. A. Wander A.G.,
 Switzerland,
        held majority shares.
 
 1976 - 3,75,000 Bonus shares issued in prop. 2:5.
 
 1978 - 6,25,000 Bonus equity shares issued in prop. 1:4.
 
 1981 - 10,00,000 Bonus equity shares issued in prop. 2:5.
 
 1984 - The major works included development of processes in basic
        manufacturing and formulations.  Two new products introduced
        during 1986 viz., Brinaldix and Mellerets are the result of
 the
        R&D of the Company.
 
      - 10,00,000 Bonus equity shares issued in prop. 2:7.
 
 1986 - At the Khandla Free Trade Zone, a modern multipurpose
 tabletting
        plant was commissioned.
 
 1987 - The pharmaceutical division received letters of intent for
 the
        manufacture of Thioridazine - a bulk drug and Pindolol a bulk
        drug and formulation.
 
      - The Chemicals' division received a letter of intent for
 oilfield,
        chemicals and an industrial licence for speciality leather
        chemicals.
 
      - The agrochemicals division received a letter of intent for
 the
        manufacture of Fluvalinate Technical, an insecticide and its
        formulations.
 
      - During February, the Company issued, 3,80,000 - 13.5%
 redeemable
        convertible debentures of Rs 180 each as rights to the equity
        shareholders in the proportion of 5 debentures for every 24
        equity shares or in multiples thereof held in the Company.
 
      - Another 20,000-13.5% convertible debentures of Rs 180 each
 were
        offered to the employees (including Indian working
        Directors)/workers of the Company.
 
      - Rs 80 out of each debenture was converted into two equity
 shares
        of Rs 10 each of the Company at a premium of Rs 30 per share
 on
        24th October.
 
      - The non-convertible portion of Rs 100 of each debenture would
 be
        redeemable by the Company at par in two equal annual
 instalments
        of Rs 50 each on the expiry of 7th and 8th years from the
 date
        of allotment.
 
 1988 - Prosan Syrup, a soya-based protein food supplement was
 introduced
        during the year.
 
      - In the domestic market `Mavrile' a brand spectrum insecticide
 was
        introduced after receiving the permanent registration.
 
 1989 - `Visken' an anti-hypertensive drug was introduced in five
        selected markets.
 
 1990 - The Dyes & Textile Chemicals division concluded a technical
        collaboration agreement with Sandoz Quinw Produckte GmbH,
 Germany
        for production of leather finishing chemicals.
 
      - The Company issued 5,00,000-14% secured non-convertible
        debentures of Rs 100 each on private placement with a bank,
 to
        meet the working capital requirement.  These debentures are to
 be
        redeemed in full at the face value on 24.7.1988.
 
      - 26,50,000 Bonus shares allotted in propn. 1:2 on 14.12.1990.
 
 1991 - With a view to reducing the working capital, the Company
        undertook to impose tighter credit policy and in addition
        increased the proportion of sales of technical grade material
 to
        formulations.
 
      - The Company took up a seeds and plantlets project, for which
        technical collaboration agreements were signed with Northrup
        King Co., U.S.A. and Zaadunie B.V., Netherlands.
 
      - The company undertook extensive trials of group speciality
 seeds
        to study their suitability under the Indian agro-climatic
        conditions.
 
 1993 - The pharmaceutical division proposed to introduced
 biotechnology
        based Leucomax for supportive therapy in cancer treatment
 etc.
        and Sandoglobulin for treatment of immune deficiency states.
 
      - Ekalux 20 AF a water based formulation with a reduced solvent
        load was commercialised in Karnataka.
 
 1994 - The Pharmaceutical division proposed to introduce the first
        synthetic long acting somatostatin analog sandostatin for
        aeromegaly and tumours of stomach, sirdalud for neurological
        disorder and Luponex for schizophrenic patients.
 
      - Ekalux 20 AF was introduced in a number of major agricultural
        areas during the year.
 
      - Several new products were added to the range of speciality
 Dyes
        and Chemicals for the textile, leather and paper industries.
 
      - During the year a virus resistant tomato variety was
 introduced
        and well received in the market.  It is proposed to set up a
        research station at Pune for evolving new hybrid varieties of
        seeds.
 
      - The agro basic plant was successfully debottlenecked at
 Kolshet
        to enable peak production levels within shorter time span.
 
      - A MOU was signed with Bhabha Atomic Research Centre for
 latest
        technology on Reverse Osmosis/Nanofiltration membrance process
 to
        help improve productivity in the manufacture of Calcium
        Lactobionate.
 
      - During the year agrochemicals AF Project was commissioned at
        Panoli.
 
 1995 - Clariant Ltd., Muttenz Switzerland identified Kolshet as one
 of
        the manufacturing sites for dyestuff and regional
 manufacturing
        site for chemicals.
 
      - The scheme of arrangement between the Company and Sandoz
 Exports
        (India) Pvt. Ltd., was sanctioned by High Court, Mumbai
 effective
        from 1st April.
 
 1996 - Liquid sulphor dyes under the brand name Diresuls were
        introduced New products viz., Bactosol range of enzymes to
 give
        stone washed' appearance on jeans, ceraperm range of
 finishing
        agent and Elfugins range of products for fibre finishing and
        Sandolube for sewability improvement were introduced.
 
      - Complete package/process concepts like laundro kwik for
        laundries/hotel industry and clarispin for processing of
        polyester fibre were launched.
 
      - Several new products viz. Relca Top & Relca Resin ranges of
        finishing chemicals were introduced.
 
      - The Spray drier capacity was increased resulting in reduction
 in
        cost of drying of dyestuffs.
 
 1997 - New products introduced during the year actively contributed
 in
        achieving sales growth despite difficult market condition. 
 The
        Company continued market leadership position in textile
        chemicals and leather dyes.
 
      - A paper application laboratory was set up to remedy
 customerised
        problem.  The Company test marketed masterbatches for
 plastics.
 
      - The company has introduced a range of new products for the
        denim sector.  
 
      - The company has introduced series of high value speciality
        finishing products for textiles.
 
 1998 - The company has introduced its new products successfully in
        Australia, Columbia and Thailand.
 
      - The company proposes to introduce new product range of
 pigment
        and additives for the coating, automotive and polymer
 industries.
 
      - Clariant has entered into a memorandum of understanding with
 Clea
        Investor Support Services for administrating the scheme.
 
      - A merger of Colour-Chem and Clariant India is `presently
 ruled
        out' and the two companies are jointly identifying areas of
        synergies and opportunities to enhance shareholder value.
 
      - Clariant India (CIL) was formed to take over the chemicals
        business of the erstwhile Sandoz India in line with the
        worldwide demerger of Sandoz's chemicals business to form
        Clariant International, Switzerland (CIS, 51% equity stake in
        CIL).
 
      - Clariant and Ciba Specialty Chemicals, the world's biggest
        makers of specialty chemicals, agreed to unite in a share
 swap
        worth at least 8.5 billion Swiss francs ($6.2 billion),
        creating the dominant company in the global $100 billion
        industry.
 
 1999 - Clariant (India) has received the prestigious Excellence
 Award
        for Innovative HR practices.
 
      - The company has clearly focussed on new products and thrust
 on
        yield improvement and capital management as a growth strategy
        despite a slowdown in the economy and sluggish market
        conditions.
 
      - The company has introduced `Sandolube' and `Ceraperm' range
 of
        fibre lubricants and finishing agents and has also introduced
 a
        series of products for industrial textiles.
 
      - The company had introduced masterbatches for polycarbonate
        polymers for the first time in India for manufacturing of
        coloured fashionable opticals.
 
      - The company introduced the concept of a customer
 documentation
        file, which contains all relevant, up-to-date information
        regarding the customers existing businesses as well as
 developing
        opportunities.
 
 2000 - Clariant (India) is setting up a new facility at Kolshet,
 Thane
        for manufacturing master batches.
 
           -Clariant India Ltd has achieved a 35.8-per cent increase
 in net profit for the six-month ended September            2001 at Rs
 10.7 crore.
 
 
 2002
 
 -Redesignates Mr B L Gaggar as the CFO and CS of the company.
 
 2003 
 
 -Chooses India for its Custom Synthesis Project.
 
 -Change in the Registered Office:
 Paville House, 3rd floor, Off. Veer Sarvarkar Marg, Prabhadevi,
 Mumbai - 400-025. Tel No: 24323434 , Fax: 24229020.
 
 2006
 
 -